223 related articles for article (PubMed ID: 12055268)
1. Suppression of autoimmune diabetes by viral IL-10 gene transfer.
Yang Z; Chen M; Wu R; Fialkow LB; Bromberg JS; McDuffie M; Naji A; Nadler JL
J Immunol; 2002 Jun; 168(12):6479-85. PubMed ID: 12055268
[TBL] [Abstract][Full Text] [Related]
2. Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10.
Kawamoto S; Nitta Y; Tashiro F; Nakano A; Yamato E; Tahara H; Tabayashi K; Miyazaki J
Int Immunol; 2001 May; 13(5):685-94. PubMed ID: 11312256
[TBL] [Abstract][Full Text] [Related]
3. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
Qin L; Ding Y; Tahara H; Bromberg JS
J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
5. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
[TBL] [Abstract][Full Text] [Related]
6. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.
Goudy K; Song S; Wasserfall C; Zhang YC; Kapturczak M; Muir A; Powers M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Ellis TM; Flotte TR; Atkinson MA
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13913-8. PubMed ID: 11717448
[TBL] [Abstract][Full Text] [Related]
8. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
9. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
[TBL] [Abstract][Full Text] [Related]
10. The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy.
Yamamoto AM; Chernajovsky Y; Lepault F; Podhajcer O; Feldmann M; Bach JF; Chatenoud L
J Immunol; 2001 Apr; 166(8):4973-80. PubMed ID: 11290776
[TBL] [Abstract][Full Text] [Related]
11. Suppression of allogeneic response by viral IL-10 gene transfer.
Fujisawa K; Saito S; Okada Y; Fujiwara T; Yagi T; Iwagaki H; Tanaka N
Cell Transplant; 2003; 12(4):379-87. PubMed ID: 12911125
[TBL] [Abstract][Full Text] [Related]
12. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice.
Lu Y; Tang M; Wasserfall C; Kou Z; Campbell-Thompson M; Gardemann T; Crawford J; Atkinson M; Song S
Hum Gene Ther; 2006 Jun; 17(6):625-34. PubMed ID: 16776571
[TBL] [Abstract][Full Text] [Related]
15. Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
J Immunol; 2011 Mar; 186(6):3779-86. PubMed ID: 21317396
[TBL] [Abstract][Full Text] [Related]
16. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice.
Hu CM; Lin HH; Chiang MT; Chang PF; Chau LY
Diabetes; 2007 May; 56(5):1240-7. PubMed ID: 17303808
[TBL] [Abstract][Full Text] [Related]
17. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
[TBL] [Abstract][Full Text] [Related]
18. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
19. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]